| Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer (NCT03825289) | University of Utah | 2019-01-30 |
| VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer (NCT03373188) | Emory University | 2017-12-15 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study (NCT02345460) | Case Comprehensive Cancer Center | 2015-09-01 |
| Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery (NCT02511821) | City of Hope Medical Center | 2015-07-22 |
| Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection (NCT02506842) | Fudan University | 2015-06-01 |
| Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer (NCT02349867) | Virginia Commonwealth University | 2015-01-29 |
| Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer (NCT02307539) | City of Hope Medical Center | 2014-11-01 |
| Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer (NCT01918644) | University of Wisconsin, Madison | 2014-04-08 |
| Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer (NCT02047474) | Yale University | 2014-03-25 |
| Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery (NCT01954732) | Case Comprehensive Cancer Center | 2014-01-01 |
| Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy (NCT02414100) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-12-12 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer (NCT01959672) | University of Nebraska | 2013-09-06 |
| Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer (NCT01897454) | Albert Einstein College of Medicine | 2012-01-27 |
| Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery (NCT01234935) | Translational Oncology Research International | 2011-01-13 |
| RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer (NCT01192763) | National Cancer Institute (NCI) | 2010-08-01 |
| Perioperative Therapy for Resectable Pancreatic Cancer (NCT00609336) | University of Washington | 2008-01-01 |
| Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT00482625) | National Cancer Institute (NCI) | 2007-06-01 |
| Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery (NCT00305877) | National Cancer Institute (NCI) | 2006-02-01 |